Technology
3D Printing Medical Devices Market size is set to grow by USD 7.07 billion from 2024-2028, Increased demand for personalized or customized medical devices boost the market, Technavio
Published
9 months agoon
By

NEW YORK, July 30, 2024 /PRNewswire/ — The global 3D printing medical devices market size is estimated to grow by USD 7.07 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 25.2% during the forecast period. Increased demand for personalized or customized medical devices is driving market growth, with a trend towards rising focus on the research for the use of 3D printing process to manufacture living organs and cell structures. However, high initial setup cost of 3d printing facility poses a challenge. Key market players include 3D Systems Corp., Anatomics Pty Ltd., Autodesk Inc., Biomerics LLC, Boston Scientific Corp., Desktop Metal Inc., EOS GmbH, Exail Technologies, Formlabs Inc., General Electric Co., INTAMSYS TECHNOLOGY CO. LTD., MATERIALISE NV, Mecuris GmbH, Medtronic Plc, Organovo Holdings Inc., Qualtech Consulting Corp., Renishaw Plc, Schultheiss GmbH, SLM Solutions Group AG, and Stratasys Ltd..
Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report
3D Printing Medical Devices Market Scope
Report Coverage
Details
Base year
2023
Historic period
2018 – 2022
Forecast period
2024-2028
Growth momentum & CAGR
Accelerate at a CAGR of 25.2%
Market growth 2024-2028
USD 7079.6 million
Market structure
Fragmented
YoY growth 2022-2023 (%)
19.78
Regional analysis
North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution
North America at 40%
Key countries
US, Germany, UK, Japan, and China
Key companies profiled
3D Systems Corp., Anatomics Pty Ltd., Autodesk Inc., Biomerics LLC, Boston Scientific Corp., Desktop Metal Inc., EOS GmbH, Exail Technologies, Formlabs Inc., General Electric Co., INTAMSYS TECHNOLOGY CO. LTD., MATERIALISE NV, Mecuris GmbH, Medtronic Plc, Organovo Holdings Inc., Qualtech Consulting Corp., Renishaw Plc, Schultheiss GmbH, SLM Solutions Group AG, and Stratasys Ltd.
Market Driver
The 3D printing of medical devices, specifically in the field of bioprinting, represents a significant advancement in healthcare technology. This process involves the precise layering of cells, biologic scaffolds, and growth factors to create bioidentical tissue, such as stem cells, skin grafts, and bone and cartilage. Unlike traditional 3D printers that use plastic or metals as raw materials, 3D bioprinters utilize a computer-guided pipette to layer living cells, referred to as bioink, to create artificial living tissues. One of the most promising applications of 3D bioprinting is in organ replacement. This technology holds the potential to address the organ donor shortage and reduce rejections by creating organs that better meet the requirements of the body. For instance, 3D printed bone features a micropore surface that allows osteocytes to adhere, join, and heal better than traditional metal implants. ORGANOVO, a biotechnology company, is pioneering the use of 3D bioprinting to develop in vivo liver tissues for treating rare, life-threatening diseases. Their product, the ExVive 3D Bioprinted Human Liver Tissues, can be used for drug exposure and metabolism studies, offering a valuable alternative to organ transplantation. Allevi and SHIBUYA are among the companies leading the way in 3D bioprinting technology. Allevi introduced the first desktop 3D bioprinter capable of printing living tissues using human cells, while SHIBUYA’s 3D bioprinter is the first cell culture system for building complex cell-based structures. The potential of 3D bioprinting is driving increased R&D efforts in developing devices for this technology. As technological advances continue, 3D printing medical devices are expected to see widespread adoption, fueling the growth of the global 3D printing medical devices market.
The 3D Printing Medical Devices market is experiencing significant growth due to its ability to produce customized, patient-specific solutions for various medical applications. Stereolithography (SLA) and digital light processing are popular 3D printing technologies used in creating prosthetics implants, orthopedic implants, and wearable medical devices. Dentistry and orthodontics also benefit from 3D printing, with applications including dentures, bone scaffolds, and hearing aids. Tissue-engineered products, remote patient monitoring, telemedicine, and vital signs monitoring are other areas where 3D printing is making an impact. Complex medical procedures, such as implantable and non-implantable medical devices, drug testing, and organ and tissue production, are also being revolutionized by this technology. Computer-aided manufacturing and design, diagnostic centers, medical institutions, and 3D printing laboratories are embracing 3D printing to provide personalized solutions. Laser beam technology, minimally invasive surgery, and surgical equipment are other areas where 3D printing is making a difference. Patient CAD images are used to create patient-specific models and customized implants, including cranial implants for neurosurgery and human skull repairs. Overall, 3D printing is transforming the medical industry by enabling the production of customized, high-quality medical devices in a layer-wise manner.
Discover 360° analysis of this market. For complete information, schedule your consultation – Book Here!
Market Challenges
The 3D printing medical devices market faces significant challenges due to high capital costs. Equipment for 3D printing or outsourced print service contracts, advanced software for post-processing, and proprietary raw materials contribute to these costs. Desktop FDM or SLA machines cost less than USD5,000, but high-end additive manufacturing printers range from USD200,000 to USD850,000 or even millions. Skilled personnel and training are also necessary, adding to the expenses. A clinical 3D printing lab requires ancillary staff for printing. Production time, ranging from hours to days, limits its use in mass manufacturing. These factors hinder the widespread adoption of 3D printers, potentially impacting the growth of the market negatively.The 3D printing medical devices market is experiencing significant growth due to the advantages it offers in creating customized solutions for various medical needs. However, there are challenges that need to be addressed. For physicians, the use of 3D-printed medical devices in elective surgical procedures requires careful consideration for complex prosthetic limbs and brain designs. Surgeons prefer titanium alloys for surgical tools, but cancer patients benefit from biocompatible materials as drug contact materials. Hearing aid manufacturers are exploring 3D-printed hearing aid devices using biocompatible materials for personalized solutions. CAD/CAM technology and desktop printers are revolutionizing dental clinics and hospitals, providing dental restoration, surgical planning, and personalized prosthetics. Orthopedic prosthetics and surgical instruments also benefit from 3D printing, improving surgical outcomes, operation time, and reducing post-surgical complications. Mechanical protection for tissues and organs is a promising area for 3D printing, with potential applications in organ transplantation and living cells using biomaterials. However, biosafety concerns and ethical issues surrounding the use of human cells and tissues need to be addressed by regulatory bodies like the Human Tissue Authority. Photopolymerization and Medical device manufacturers are using rapid prototyping to innovate, while healthcare professionals embrace the technology for prosthetics, surgical instruments, personalized prosthetics, orthotics, surgeon comfort, and fatigue prevention.
For more insights on driver and challenges – Request a sample report!
Segment Overview
This 3d printing medical devices market report extensively covers market segmentation by
Application 1.1 Orthopedic and spinal1.2 Dental1.3 Hearing aids1.4 OthersEnd-user 2.1 Hospitals and clinics2.2 Academic institutes2.3 Pharma and biotech companies2.4 OthersGeography 3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)
1.1 Orthopedic and spinal- The 3D printing medical devices market encompasses the production of orthopedic and spinal implants using 3D printing technology. This technology enables the fabrication of standard-sized implants, patient-matched implants, and custom implants for individuals with deformities. Hospitals and ambulatory surgery centers are major end-users, as 3D printing allows for the creation of complex structures and individualized implants. Orthopedic and spinal applications dominate the market due to the rising prevalence of related disorders, increasing demand for personalized implants, and the need for advanced surfaces and structures. The technology’s ability to manufacture lattice structures and porous surfaces promotes bone ingrowth and improves implant stability. Titanium implants, commonly used in orthopedics, benefit from 3D printing’s ability to create greater porosity, enhancing bony ingrowth and improving implant stability. In the field of prosthetics, 3D printing significantly reduces manufacturing time and costs while maintaining functionality. The technology’s affordability makes it particularly suitable for children who quickly outgrow their prosthetic limbs. Vendors are increasing investments in R&D to develop advanced orthopedic and spinal implants, further fueling market growth. Key factors driving the market include the aging population, increasing prevalence of orthopedic and spinal disorders, and the demand for customized implants. These factors are expected to propel the growth of the global 3D printing medical devices market during the forecast period.
For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) – Download a Sample Report
Research Analysis
The 3D printing medical devices market is revolutionizing the healthcare industry by enabling the production of customized medical products in a layer-wise manner using CAD images. This technology allows for the creation of patient-specific products, including implants, hearing aids, bone scaffolds, surgical equipment, and more. The process begins with the creation of patient CAD images, which are then used to manufacture standard implants or personalized prosthetics, surgical instruments, and orthotics. The benefits of 3D printing in medical devices extend beyond patient comfort, as it also allows for the production of implantable and non-implantable medical devices using biomaterials, as well as drug testing and potential applications in organ transplantation and tissue engineering. Rapid prototyping and computer-aided manufacturing are key technologies driving the growth of this market, with healthcare professionals and medical device manufacturers embracing the technology to improve patient outcomes and surgical procedures.
Market Research Overview
The 3D printing medical devices market is revolutionizing the healthcare industry by enabling the production of customized medical products in a layer-wise manner using CAD images. This technology allows for the creation of patient-specific products such as implants, hearing aids, bone scaffolds, surgical equipment, and more. The use of patient CAD images ensures a perfect fit and optimal surgical outcomes, reducing operation time and post-surgical complications. 3D printing technology is being applied in various medical fields, including neurosurgery, orthopedics, and dentistry. For instance, it is used to create cranial implants, patient-specific models, and surgical tools for complex procedures. The use of biocompatible materials, such as titanium alloys and photopolymers, ensures the safety and effectiveness of 3D-printed medical devices. The market for 3D-printed medical devices is vast and diverse, encompassing elective surgical procedures, complex prosthetic limbs, brain designs, surgical instruments, and more. The technology is also being used in tissue engineering and organ transplantation, with the potential to print living cells and biomaterials. However, the use of 3D printing in medicine raises biosafety concerns and ethical issues, particularly with regard to the Human Tissue Authority and patient privacy. Medical device manufacturers are working to address these challenges through the use of CAD/CAM technology, rapid prototyping, and collaboration with healthcare professionals. The market for 3D-printed medical devices includes hearing aid manufacturers, dental clinics, hospitals, and surgical planning centers. The technology is also being used to create implantable and non-implantable medical devices, wearable medical devices, and diagnostic tools. The potential applications of 3D printing in medicine are vast, from surgical planning and dental restoration to remote patient monitoring and telemedicine. The future of medicine is undoubtedly 3D printed.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
ApplicationOrthopedic And SpinalDentalHearing AidsOthersEnd-userHospitals And ClinicsAcademic InstitutesPharma And Biotech CompaniesOthersGeographyNorth AmericaEuropeAsiaRest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/3d-printing-medical-devices-market-size-is-set-to-grow-by-usd-7-07-billion-from-2024-2028–increased-demand-for-personalized-or-customized-medical-devices-boost-the-market-technavio-302209578.html
SOURCE Infiniti Research, Inc.
You may like
Technology
Wallarm Unveils Findings from Q1 2025 API Threat Report, Uncovering Evolving API Threats Across Multiple Industries
Published
27 minutes agoon
April 24, 2025By

Half of all security issues in Agentic AI code repositories (65%) are API-related
SAN FRANCISCO, April 24, 2025 /PRNewswire/ — Wallarm, the leader in API and AI security solutions, today announced the findings of The Rise of Agentic AI, the API ThreatStats report for Q1 2025. The report found that evolving API threats are fueled by the rise of agentic AI systems, growing complexity in cloud-native infrastructure, and a surge in software supply chain risks, and uncovered patterns and actionable insights to help organizations prioritize risks and harden their defenses.
“In the first quarter of 2025, overall API threats continued to increase across multiple industries, from healthcare to AI and beyond,” said Ivan Novikov, CEO and Co-Founder of Wallarm. “Our research shows that AI agent security risk largely stems from APIs. Agentic AI presents the same problems as any other type of code, but agentic AI exhibits a large percentage of API-related vulnerabilities. We can’t address agentic AI security without directly addressing APIs.”
While APIs are central to all Agentic workflows, cybersecurity standards such as CVE and CISA KEV are trailing indicators of API and overall security risks presented by Agentic AI. In order to gain insights into current and future trends, Wallarm researchers took a deep dive into GitHub security issues going back to 2019 for Agentic repositories. Of the 2,869 security issues analyzed in Agentic AI projects, they found that the majority were API-related (65%), underscoring the inseparability of agent and API security.
The report also analyzed API breaches that occurred in Q1 2025. No industry was immune, as highlighted by breaches impacting organizations such as Oracle Cloud, DeepSeek, CommonCrawl, Volkswagen, National Health Service (NHS) UK, Microsoft, BeyondTrust, and OmniGPT.
Key findings include:
The majority of all security issues in Agentic AI repositories (65%) are API-related and over 700 issues remain unaddressed.25% of reported security issues remain open, with some lingering for 1,200-plus days, highlighting a critical gap between vulnerability discovery and remediation.The top five API breaches span cloud, AI, automotive, and healthcare, underscoring industry-wide concerns and urgent relevance to cybersecurity worldwide.With 60% of top vulnerabilities found to be access control-related, access control remains prevalent across APIs.
APIs are not just part of the attack surface — they are the attack surface. From legacy system exposures to AI-native risks, attackers are increasingly targeting APIs as both the entry point and objective. In order to protect themselves from these threats, organizations need to take proactive measures to ensure existing threat models account for the current environment and prioritize API security by updating API threat models and security workflows, creating Agentic AI security strategies, implementing real-time monitoring of API traffic, and updating both threat intelligence and API discovery methodology.
To download the full Q1 2025 API Threat Report, visit http://www.wallarm.com/reports/q1-2025-wallarm-api-threatstats-report.
About Wallarm
Wallarm is the only unified platform for API and agentic AI security successfully deployed in enterprise production environments. With Wallarm, customers receive the fastest, easiest, and most effective way to stop API attacks. Period. Organizations choose Wallarm to protect their APIs and AI agents because the platform delivers a complete inventory of APIs, real-time blocking, and patented AI/ML-based abuse detection. Wallarm is headquartered in San Francisco, California, and is backed by Toba Capital, Y Сombinator, Partech, and other investors.
Media Contact:
Michelle Kearney
Hi-Touch PR
443-857-9468
kearney@hi-touchpr.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/wallarm-unveils-findings-from-q1-2025-api-threat-report-uncovering-evolving-api-threats-across-multiple-industries-302436289.html
SOURCE Wallarm
Technology
Infinitus Launches First Trusted Voice AI Agents for Healthcare
Published
27 minutes agoon
April 24, 2025By

Proprietary hallucination-free AI agent architecture protects patients and providers in a proven enterprise-scale voice AI platform
SAN FRANCISCO, April 24, 2025 /PRNewswire/ — Infinitus Systems, Inc., the AI company that has powered more than 100 million minutes of healthcare conversations that accelerate care for over a million patients, today announced the first patient- and provider-facing voice AI agents built for use cases where trust is critical.
The Infinitus voice AI platform was built to ensure patients’ and providers’ trust in AI agents that can transform the patient experience with accurate, around-the-clock access to provider- or payor-curated expertise. Infinitus has advanced its proven multi-modal, multimodel platform for content-rich, often complex patient conversations that can include over 100 exchanges, ensuring they adhere to approved content and provider and plan procedures, as well as regulatory requirements. Infinitus is the first voice AI architecture to include four innovations designed to build trust with providers and their patients:
AI response control for trusted responses: A proprietary discrete action space leverages the power of LLMs to understand and facilitate conversations, while ensuring AI agents do not hallucinate or generate any responses that are inaccurate or outside of the approved standard operating procedure of customers or regulatory agencies.Specialized knowledge graph for trusted information exchange: The Infinitus knowledge graph allows agents to contextualize and verify information in real time, validating information provided by a patient or payor agent against trusted sources specific to the payor plan, treatment area, patient history, customer-provided knowledge bases, and more.AI review for trusted outcome: This automated post-processing and verification system incorporates human-level reasoning gathered from experience performing millions of tasks. The AI evaluates a conversation output to determine whether a response, as well as any extracted information, is accurate given the context of the task, providing a critical level of oversight that is impossible to achieve manually. When necessary, AI agents can flag a human and suggest follow-up actions.Robust security and compliance program for trusted processes: Infinitus adheres to SOC 2 and HIPAA requirements, which includes bias testing, protected health information (PHI) redaction, and data retention for secure, unbiased data handling.
While agents have been used widely in healthcare applications, they have not yet been purposefully designed to earn clinician and patient trust.
“As a patient, the most important questions come after hours, when care teams are off duty or asleep. AI agents can help reduce that anxiety and empower patients at any time, no matter where they are. But that can only happen when trust and accountability are built into the technology,” said Ankit Jain, CEO and co-founder of Infinitus. “We believe we are the first to deliver on the trust you should expect in healthcare at every level of our platform.”
Patient and Provider-Facing AI Agents
Infinitus’ AI agents can proactively call patients with prompts, requests, and follow-ups, as well as provide around-the-clock availability for patient calls to answer questions and provide assistance across their healthcare journey. AI agents improve healthcare literacy and support medication adherence, promptly escalating any reported side effects, particularly benefiting individuals managing chronic conditions or with specialty medication needs.
Provider-facing agents deliver accurate and reliable details to providers, helping simplify reimbursements for a seamless experience. Through automated calls to providers, Infinitus’ AI agents simplify care coordination and save time, ensuring the appropriate clinical documentation, signatures, or approvals are submitted, preventing delays and improving patient access to therapies. Infinitus’ provider-facing AI agents can also keep providers informed on treatments and policies, helping them deliver the highest-quality patient care without administrative burden.
Zing Health, a Medicare Advantage provider offering personalized care to chronically underserved populations across the U.S., has deployed Infinitus’ patient-facing AI agents to perform comprehensive member health evaluations to extend its staff resources and provide a more consistent experience.
“Infinitus has become a key part of our onboarding process by efficiently completing health risk assessments within the first 60 days of a new member’s journey. The health risk assessment is a vital step in Zing’s Model of Care. Responses provide early insights into our members’ healthcare needs, enabling us to deliver a personalized engagement, customized care, and dedicated support from the beginning,” said Meghan Speidel, COO at Zing Health. “Since deploying Infinitus AI agents, our team is able to focus on members with active and immediate needs, where focused attention has the highest impact.”
“In healthcare, only trust can unlock the full value of any innovation,” said Shyam Rajagopalan, CTO and co-founder of Infinitus. “We designed Infinitus’ AI agents to ensure clinical conversations are not only maximally valuable to patients and providers, but trusted and compliant during some of the most sensitive moments in a patient’s journey.”
Expansion of Payor-Facing AI Agents
New payor-facing AI agent offerings now support payors, for instance, in insurance discovery and prior-authorization follow-ups. New digital offerings include Medicare Part B and Medicare Beneficiary Identifier (MBI) look-up, enabling providers to reduce delays in verifying eligibility, helping patients receive the data necessary to access and afford care. Infinitus’ expanded payor-facing offerings reinforce the company’s commitment to reducing administrative burden and advancing innovation across the healthcare ecosystem.
This comes on the heels of securing a spot on Fast Company’s World’s Most Innovative Companies of 2025 list, honoring the healthcare businesses shaping the industry.
About Infinitus
Infinitus is the leader in trusted AI agents and copilots for healthcare that improve the patient, clinician and staff experience. Infinitus’ AI voice agents and copilots help automate, expedite, and simplify time-consuming but critical conversational touchpoints that drive patient, clinician, and staff frustration and dissatisfaction. Infinitus’ proven AI native architecture combines multimodal, multi-model AI with a robust knowledge graph, a proprietary discrete action space, and human-in-the-loop guardrails to ensure data accuracy, safety, and support for healthcare organizations at scale. Infinitus was recently named to Fast Company’s World’s Most Innovative Companies of 2025 and is a trusted solutions partner to 44% of Fortune 50 healthcare companies. Learn more at https://www.infinitus.ai/
View original content to download multimedia:https://www.prnewswire.com/news-releases/infinitus-launches-first-trusted-voice-ai-agents-for-healthcare-302436349.html
SOURCE Infinitus Systems, Inc.
Technology
Akamai Empowers Partners to Deliver Services and Support
Published
27 minutes agoon
April 24, 2025By

Certified partners can now deliver Day-2 Operations Services for Akamai API solutions and technical support for Akamai Guardicore Segmentation environments
CAMBRIDGE, Mass., April 24, 2025 /PRNewswire/ — Akamai Technologies (NASDAQ: AKAM), the cybersecurity and cloud computing company that powers and protects business online, today announced updates to its Security Certified Service Provider programs for API security solutions and for Akamai Guardicore Segmentation. Certified partners can now offer Day-2 Operations Services related to Akamai API security products and solutions, just as they do for Akamai Guardicore Segmentation. Additionally, they can provide Akamai Guardicore Segmentation technical support directly to their customers.
According to a recent Akamai State of the Internet (SOTI) report, API attacks come in various forms, including data breaches, abuse, and distributed denial-of-service attacks. In fact, Akamai recorded 108 billion API attacks from January 2023 through June 2024. These attacks can lead to data theft, reputation damage, regulatory fines, and significant financial losses, highlighting the importance of securing APIs.
“The enhancements Akamai has made to its Security Certified Service Provider programs enable us to better deliver services directly to our customers, significantly increasing our ability to meet their unique needs and ensure they receive the best possible protection and support,” said Florent Houy, Head of Cloud Innovation at Orange Cyberdefense in France. “These partner program updates strengthen our collective capability and Orange Cyberdefense’s microsegmentation service offering to secure digital assets, ensure flexibility, meet our customers’ expectations, and help our clients stay focused on what matters most: their business.”
“The channel is the backbone of the cybersecurity industry where everyone wins — technology providers expand their reach, partners grow their business, and customers get the best security solutions tailored to their needs,” said Paul Joseph, Executive Vice President, Global Sales and Services at Akamai. “Empowering our partners with the right tools, training, and support is key to driving success. These enhancements to the Akamai channel program position our partners as their customers’ trusted security advisor and single point of contact, empowering both partner and customer to accelerate the growth of their business.”
Ongoing Day-2 Operations Services are essential for maintaining a strong security posture as organizations refine their segmentation and API security strategies.
Day-2 Operations Services for API security includes:
Operational and management services — Enable partners to maximize their value to customers through hybrid deployments, quarterly business reviews, and API audits and complianceSecurity incident management services — Allow partners to connect customer API security deployments to their Security Operations Center so partner incident response teams receive detection alerts from Akamai API Security and any other solutions deployedActive testing — Enables customers to identify and remediate API vulnerabilities before they are deployed to production, which can help eliminate risk and save on remediation costs
Guardicore Certified Services Partners are now able to provide the full suite of services of the microsegmentation lifecycle from project delivery to 24/7 first-line support to day-2 operations to keep the policy up to date and monitor potential security incidents while maintaining compliance. Akamai Guardicore Segmentation customers now have a choice to use their local certified partners to provide them the entire services suite.
Day-2 Operations Services for Akamai Guardicore Segmentation includes:
Segmentation administration services — Allow partners to maximize the value of their customer’s Akamai Guardicore Segmentation deployment by updating and expanding their implementationSecurity incident management services — Allow partners to connect their customer’s Akamai Guardicore Segmentation deployment to their Security Operations Center and use it to contain threats by preventing lateral movement and isolate infected assets until resolutionAudit and compliance services — Allow partners to streamline audit and compliance management by providing a single source of truth about what is communicating in their customer’s networks, and enable consistent policy enforcement across their environment
Learn more about Akamai’s Security Certified Service Provider programs.
About Akamai
Akamai is the cybersecurity and cloud computing company that powers and protects business online. Our market-leading security solutions, superior threat intelligence, and global operations team provide defense-in-depth to safeguard enterprise data and applications everywhere. Akamai’s full-stack cloud computing solutions deliver performance and affordability on the world’s most distributed platform. Global enterprises trust Akamai to provide the industry-leading reliability, scale, and expertise they need to grow their business with confidence. Learn more at akamai.com and akamai.com/blog, or follow Akamai Technologies on X and LinkedIn.
Contacts
Akamai PR
AkamaiPR@akamai.com
Investor relations
IR-InvestorRelations@akamai.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/akamai-empowers-partners-to-deliver-services-and-support-302436210.html
SOURCE Akamai Technologies


Wallarm Unveils Findings from Q1 2025 API Threat Report, Uncovering Evolving API Threats Across Multiple Industries

Infinitus Launches First Trusted Voice AI Agents for Healthcare

Akamai Empowers Partners to Deliver Services and Support

Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network

New Gooseneck Omni Antennas Offer Enhanced Signals in a Durable Package

Huawei Launches Global City Intelligent Twins Architecture to Accelerate City Digital Transformation

Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs

Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network

NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Coin Market5 days ago
Crypto industry is not experiencing regulatory capture — Attorney
-
Coin Market4 days ago
Over 13K institutions exposed to Strategy as Saylor hints at BTC buy
-
Near Videos3 days ago
NEAR AI Ecosystem – What Did You Ship This Week 5 – AI Agents That Apply to Jobs for You
-
Coin Market5 days ago
Charles Schwab CEO eyes spot Bitcoin trading by April 2026
-
Technology5 days ago
Charmerly Study Reveals ‘Mails’ as the Most Popular Feature Among Users
-
Coin Market4 days ago
Altcoin unit bias 'absolutely destroying' crypto newbies — Samson Mow
-
Coin Market5 days ago
'Rich Dad, Poor Dad' author calls for $1 million BTC by 2035
-
Technology4 days ago
NASA Astronaut Don Pettit, Crewmates Complete Space Station Expedition